Kerydin (PharmaDerm, A division of Fougera Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Kerydin drug offered from PharmaDerm, A division of Fougera Pharmaceuticals Inc.. This Oxaborole Antifungal [EPC],Protein Synthesis Inhibitors [MoA],Boron Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | PharmaDerm, A division of Fougera Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Tavaborole |
| SUBSTANCE NAME: | TAVABOROLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Oxaborole Antifungal [EPC],Protein Synthesis Inhibitors [MoA],Boron Compounds [Chemical/Ingredient] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-07-07 |
| END MARKETING DATE: | 0000-00-00 |
Kerydin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Kerydin from PharmaDerm, A division of Fougera Pharmaceuticals Inc. |
| LABELER NAME: | PharmaDerm, A division of Fougera Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 43.5(mg/mL) |
| START MARKETING DATE: | 2014-07-07 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 10337-905_86e84f54-0a55-4f1f-99f0-d8d5a26a5d30 |
| PRODUCT NDC: | 10337-905 |
| APPLICATION NUMBER: | NDA204427 |
Other TAVABOROLE Pharmaceutical Manufacturers / Labelers:
